(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS SERUM AMYLOID A (AA) AND IMMUNOGLOBULIN AMYLOID LIGHT CHAIN (AL)], MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-449) [VH (MUS MUSCULUS IGHV10- 1*02 (89.8%)/HOMO SAPIENS IGHV3-72*01 (84.0%) - (IGHD) -HOMO SAPIENS IGHJ4*01 (92.9%)) [8.10.10] (1- 119) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 (CH1 R120 (216) (120-217), HINGE (218-232), CH2 (233-342), CH3 E12 (358), M14 (360) (343-447), CHS (448-449)) (120-449)], (222-219')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'- 219') [V-KAPPA (MUS MUSCULUS IGKV1-110*01 (91.0%)/HOMO SAPIENS IGKV2-30*02 (87.0%) -HOMO SAPIENS IGKJ4*01 (91.7%)) [11.3.9] (1'-112') -HOMO SAPIENS IGKC*01, KM3A45.1 (158), V101 (196)(113'- 219')]; DIMER (228-228'':231-231'')-BISDISULFIDE. PROPOSED INN: LIST 119(WHO)
BIRTAMIMABUM(INN)